USE OF DARBEPOETIN ALFA (ARANESP®) FOR ANEMIA TREATMENT IN CHILDREN WITH CHRONIC KIDNEY DISEASE - CLINICAL EXPERIENCE OF BULGARIAN PEDIATRIC GROUP

• Main Authors: Maria Gaydarova (Author), Anelia Boueva (Author), Svetlana Marinova (Author), Galina Zlatanova (Author)
• 格式: 图书
• 出版: Peytchinski Publishing, 2017-01-01T00:00:00Z.
• 主题: article
• 在线阅读: Connect to this object online.

Darbepoetin alfa (DA) is indicated for treatment of symptomatic anemia related to chronic kidney disease (CKD) in adult and pediatric patients. In comparison with the recombinant human erythropoietin (rHuEpo), darbepoetin alfa has two additional carbohydrates containing sialic acid which prolong its...